252 related articles for article (PubMed ID: 7737042)
1. Physiologically based pharmacokinetic model for the inhibition of acetylcholinesterase by organophosphate esters.
Gearhart JM; Jepson GW; Clewell HJ; Andersen ME; Conolly RB
Environ Health Perspect; 1994 Dec; 102 Suppl 11(Suppl 11):51-60. PubMed ID: 7737042
[TBL] [Abstract][Full Text] [Related]
2. Physiologically based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropylfluorophosphate.
Gearhart JM; Jepson GW; Clewell HJ; Andersen ME; Conolly RB
Toxicol Appl Pharmacol; 1990 Nov; 106(2):295-310. PubMed ID: 2256118
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity analysis on a physiologically-based pharmacokinetic and pharmacodynamic model for diisopropylfluorophosphate-induced toxicity in mice and rats.
Chen K; Teo S; Seng KY
Toxicol Mech Methods; 2009 Oct; 19(8):486-97. PubMed ID: 19788408
[TBL] [Abstract][Full Text] [Related]
4. Repeated exposures to diisopropylfluorophosphate result in structural disruptions of myelinated axons and persistent impairments of axonal transport in the brains of rats.
Naughton SX; Hernandez CM; Beck WD; Poddar I; Yanasak N; Lin PC; Terry AV
Toxicology; 2018 Aug; 406-407():92-103. PubMed ID: 29894704
[TBL] [Abstract][Full Text] [Related]
5. Modification of acetylcholinesterase during adaptation to chronic, subacute paraoxon application in rat.
Milatovic D; Dettbarn WD
Toxicol Appl Pharmacol; 1996 Jan; 136(1):20-8. PubMed ID: 8560475
[TBL] [Abstract][Full Text] [Related]
6. Different role of carboxylesterases in toxicity and tolerance to paraoxon and DFP.
Dettbarn WD; Yang ZP; Milatovic D
Chem Biol Interact; 1999 May; 119-120():445-54. PubMed ID: 10421482
[TBL] [Abstract][Full Text] [Related]
7. A physiologically based pharmacokinetic and pharmacodynamic model for paraoxon in rainbow trout.
Abbas R; Hayton WL
Toxicol Appl Pharmacol; 1997 Jul; 145(1):192-201. PubMed ID: 9221837
[TBL] [Abstract][Full Text] [Related]
8. Fullerene antioxidants decrease organophosphate-induced acetylcholinesterase inhibition in vitro.
Ehrich M; Van Tassell R; Li Y; Zhou Z; Kepley CL
Toxicol In Vitro; 2011 Feb; 25(1):301-7. PubMed ID: 20888407
[TBL] [Abstract][Full Text] [Related]
9. Choline derivatives and sodium fluoride protect acetylcholinesterase against irreversible inhibition and aging by DFP and paraoxon.
Dehlawi MS; Eldefrawi AT; Eldefrawi ME; Anis NA; Valdes JJ
J Biochem Toxicol; 1994 Oct; 9(5):261-8. PubMed ID: 7853361
[TBL] [Abstract][Full Text] [Related]
10. Avian embryonic brain reaggregate culture system. II. NTE activity discriminates between effects of a single neuropathic or nonneuropathic organophosphorus compound exposure.
Funk KA; Liu CH; Higgins RJ; Wilson BW
Toxicol Appl Pharmacol; 1994 Jan; 124(1):159-63. PubMed ID: 8291056
[TBL] [Abstract][Full Text] [Related]
11. Kinetic analysis of the in vitro inhibition, aging, and reactivation of brain acetylcholinesterase from rat and channel catfish by paraoxon and chlorpyrifos-oxon.
Carr RL; Chambers JE
Toxicol Appl Pharmacol; 1996 Aug; 139(2):365-73. PubMed ID: 8806854
[TBL] [Abstract][Full Text] [Related]
12. A Physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model for the organophosphate insecticide chlorpyrifos in rats and humans.
Timchalk C; Nolan RJ; Mendrala AL; Dittenber DA; Brzak KA; Mattsson JL
Toxicol Sci; 2002 Mar; 66(1):34-53. PubMed ID: 11861971
[TBL] [Abstract][Full Text] [Related]
13. Comparative sensitivity of bovine and rodent acetylcholinesterase to in vitro inhibition by organophosphate insecticides.
Cohen SD; Williams RA; Killinger JM; Freudenthal RI
Toxicol Appl Pharmacol; 1985 Dec; 81(3 Pt 1):452-9. PubMed ID: 2417385
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of diisopropylfluorophosphate, sarin, soman, and tabun on toxicity and brain acetylcholinesterase activity in mice.
Tripathi HL; Dewey WL
J Toxicol Environ Health; 1989; 26(4):437-46. PubMed ID: 2709438
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment for acute exposure to diisopropylfluorophosphate: in vivo efficacy of various acetylcholinesterase inhibitors.
Lorke DE; Hasan MY; Nurulain SM; Shafiullah M; Kuča K; Petroianu GA
J Appl Toxicol; 2011 Aug; 31(6):515-23. PubMed ID: 20981864
[TBL] [Abstract][Full Text] [Related]
16. Genetically determined differences in acute responses to diisopropylfluorophosphate.
Smolen A; Smolen TN; Wehner JM; Collins AC
Pharmacol Biochem Behav; 1985 Apr; 22(4):623-30. PubMed ID: 3991771
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms involved in the development of tolerance to DFP toxicity.
Gupta RC; Patterson GT; Dettbarn WD
Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S17-28. PubMed ID: 4092885
[TBL] [Abstract][Full Text] [Related]
18. Acetylcholinesterase inhibition and protection by dizocilpine (MK-801) enantiomers.
Galli A; Mori F
J Pharm Pharmacol; 1996 Jan; 48(1):71-6. PubMed ID: 8722500
[TBL] [Abstract][Full Text] [Related]
19. Diisopropylfluorophosphate inhibits acetylcholinesterase activity and disrupts somitogenesis in the zebrafish.
Hanneman EH
J Exp Zool; 1992 Aug; 263(1):41-53. PubMed ID: 1645120
[TBL] [Abstract][Full Text] [Related]
20. In vitro reactivation kinetics of paraoxon- and DFP-inhibited electric eel AChE using mono- and bis-pyridinium oximes.
Gupta B; Sharma R; Singh N; Kuca K; Acharya JR; Ghosh KK
Arch Toxicol; 2014 Feb; 88(2):381-90. PubMed ID: 24065055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
